International Expansion Extends to 21
Countries
TSX | NYSE: ACB
EDMONTON, Nov. 27, 2018 /PRNewswire/ - Aurora Cannabis Inc.
("Aurora" or the "Company") (NYSE:ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today
that the company has received an export request, has secured the
required export permit and has now completed its first shipment of
medical cannabis products to the Czech
Republic, making this the 21st country in which
the company operates.
The initial purchase order was placed by, and products will be
shipped to Czech Medical Herbs s.r.o. ("CMH"), a Czech
pharmaceutical wholesaler, who will subsequently supply pharmacies
throughout the country. Czech Medical Herbs is a distributor of
medicinal products with a specialization in Cannabis for medical
use and medicinal products based on cannabinoids.
"This supply arrangement demonstrates our ability to enter into
new jurisdictions as the partner of choice in new markets with
strong barriers to entry, and is testament to the strength and
business execution of our European business development team," said
Neil Belot, Chief Global Business
Development Officer. "The Czech
Republic represents the 21st country in which we
operate, and exemplifies how we are rapidly expanding our global
footprint in the medical cannabis space. We look forward to
building a long-term relationship with our customer, CMH, and
supplying patients in the Czech
Republic with our high-quality cannabis products."
Cannabis for medical purposes was regulated in the Czech Republic, a country with approximately
10 million people, in 2013 and has since been legal as a prescribed
form of medication. The law allows patients a total of 180 grams of
dry flower product per month, as prescribed by specialized
physicians, and can be obtained using an electronic prescription
form. While the country has some domestic production, product
availability remains limited and importing products from federally
licensed producers with EU GMP cultivation facilities, like Aurora,
will continue to augment supply and help meet growing market
demand.
About Aurora
Headquartered in Edmonton, Alberta,
Canada with funded capacity in excess of 500,000 kg per
annum and sales and operations in 21 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of
high quality product at low cost. Intended to be replicable and
scalable globally, our production facilities are designed to
produce cannabis of significant scale, with high quality,
industry-leading yields, and low per gram production costs. Each of
Aurora's facilities is built to meet EU GMP standards, and its
first production facility, the recently acquired MedReleaf Markham
facility, and its wholly owned European medical cannabis
distributor Aurora Deutschland, have achieved this level of
certification.
In addition to Aurora's rapid organic growth and strong
execution on strategic M&A, which to date includes 15 wholly
owned subsidiary companies – MedReleaf, CanvasRX, Peloton
Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator,
BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics,
Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela,
and ICC – Aurora is distinguished by its reputation as a partner
and employer of choice in the global cannabis sector, having
invested in and established strategic partnerships with a range of
leading innovators, including: Radient Technologies Inc. (TSXV:
RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd.
(ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom
Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty
Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC:
CTTH), and Alcanna Inc. (TSX: CLIQ).
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and are a constituent of the S&P/TSX Composite
Index.
For more information about Aurora, please visit our investor
website, investor.auroramj.com
Terry Booth, CEO
Aurora Cannabis Inc.
Caution Concerning Forward-Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur and include, but are not limited to the
variety of cannabis products that Aurora will supply to the adult
use market.. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term
is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-to-ship-medical-cannabis-to-the-czech-republic-300755600.html
SOURCE Aurora Cannabis Inc.